Finger Lakes Clinical Research

Finger Lakes Clinical Research was a Rochester, NY-based clinical research site specializing in central nervous system disorders. It conducted outpatient and inpatient clinical trials from Phase I through III across psychiatric and neurological conditions including depression, schizophrenia, anxiety disorders, bipolar disorder, dementia/Alzheimer’s disease and ADHD. The company also ran vaccine studies such as COVID and pneumonia vaccines. Founded by Dr. Sarah Atkinson in the early 2000s, it developed a reputation for high-quality CNS trial execution before being acquired by Evolution Research Group in April 2019. The company has since ceased operations under its original name and location.